Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05310786 · ClinicalTrials.gov registry record · NA
Implementing a Pharmacist-Integrated Collaborative Model of Medication Treatment for Opioid Use Disorder
A NA study, sponsored by Trustees of Dartmouth College.
- Completed
- Registry status
- NA
- Development phase
- 149
- Enrollment target
NCT05310786 is a NA study that has completed, run by Trustees of Dartmouth College. The registered enrollment target is 149 participants.
The verdict
NCT05310786, a NA study, has completed, sponsored by Trustees of Dartmouth College.
- COMPLETED
- Registry status
- NA
- Development phase
- 149 participants
- Enrollment target
Study Summary
This project will provide novel empirical information about how to optimally engage pharmacists and pharmacies as key partners in collaborative integrated care models designed to expand access to evidence-based medication treatment for OUD which may inform a larger experimental design that seeks to evaluate best ways to scale-up this model across the nation. This Phase 1 project seeks to evaluate the feasibility, acceptability, and impact of implementing a pharmacist-integrated model of MOUD into approximately four diverse outpatient clinical sites.
Interventions
- OTHER Pharmacist-integrated Medication Treatment for Opioid Use Disorder (PrIMO)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 149 participants |
| Start Date | 2022-08-18 |
| Est. Completion | 2025-02-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05310786
The ClinicalTrials.gov registry entry for NCT05310786 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 149 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Trustees of Dartmouth College, which has 31 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pharmacist-integrated Medication Treatment for Opioid Use Disorder (PrIMO) is the first listed.
NCT05310786 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05310786 about?
NCT05310786 is a clinical study titled "Implementing a Pharmacist-Integrated Collaborative Model of Medication Treatment for Opioid Use Disorder". This project will provide novel empirical information about how to optimally engage pharmacists and pharmacies as key partners in collaborative integrated care models designed to expand access to evidence-based medication treatment for OUD which may inform a larger experimental design that seeks to ...
What is the current status of trial NCT05310786?
This trial is currently completed. It is a NA study. The enrollment target is 149 participants. The study started on 2022-08-18. Estimated completion is 2025-02-05.
What interventions are being tested in trial NCT05310786?
The interventions under investigation include: Pharmacist-integrated Medication Treatment for Opioid Use Disorder (PrIMO) (OTHER).
Who is sponsoring clinical trial NCT05310786?
This trial is sponsored by Trustees of Dartmouth College, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.